Gram-positive and Gram-negative bacteria, albeit that activity was generally higher for the former. The antibiofilm activity was then determined against a clinical isolate of meticillin-resistant Staphylococcus aureus (MRSA). Strikingly, the copper complexes tested showed significant activity against biofilms, and were better in the removal of biofilms than vancomycin, an antibiotic that is currently used in the treatment of MRSA infections.
INTRODUCTION
Most bacteria live in complex sessile communities called biofilms. In these, bacteria adhere to surfaces and are embedded in a matrix of self-generated extracellular polymeric substances. Biofilms play a major role in the lifestyle of bacteria and indeed are involved in the majority of bacterial infections [1] . Well-known examples include biofilms forming on living tissue, such as in wound infections, endocarditis or lung infections in cystic fibrosis patients, as well as biofilms on indwelling medical devices such as stents, catheters or prosthetic implants [2] .
A particular problem of infections caused by biofilms is that they are difficult to treat.
Generally, biofilms are much more tolerant to both antibiotics and the immune system as compared to their planktonic (free-floating) counterparts [3] . Often the resistance of biofilms towards antibiotics may be as much as 100-1000 fold higher than that of planktonic cells [4] , and sub-inhibitory concentrations of certain antibiotics may even induce biofilm formation [5] . Several factors play a role in this including an altered physiological state, slow growth rate of bacteria in biofilms [3] and a limited penetration of antibiotics through biofilms [6, 7] .
A number of strategies are currently being investigated in order to improve treatment of bacterial infections. In recent years there has been an increased interest in the use of metals such as copper, silver or platinum as antibacterial agents. For instance, silver is increasingly being used in wound dressings and other products [8] . Metallic copper has been shown to be effective as an antimicrobial surface that is useful in e.g.
wound dressings or as a material for common hospital surfaces [9, 10] . In addition, copper incorporated in paints has also been shown to inhibit biofilm formation of bacteria and could thus be employed as an antifouling agent [11] .
Coordination complexes of metals with aromatic ligands are also attractive molecules with a demonstrated antibacterial and cytotoxic activity. In these, the metal acts as a scaffold for the ligands, forming a 3D structure that interacts with specific targets.
Early work by the group of Dwyer demonstrated that coordination complexes of Ru(II), Ni(II), Cu(II), Fe(II) or Co(II) with ligands such as 1,10-phenanthroline or 2,2'-bipyridine have activity against both Gram-positive and Gram-negative bacteria [12, 13] . As recently reviewed by us, these complexes interact with DNA through intercalation [14] . It is important to note that complex formation is important, as the biological activity is significantly enhanced when compared to ligands or metals alone [15, 16] . In addition, copper(II) complexes may also have chemical nuclease activity [17] , and several groups have designed and explored complexes which facilitate DNA transformations [18] [19] [20] .
In recent years we have investigated the antimicrobial activity of compounds containing iron, ruthenium, copper and palladium [16, [21] [22] [23] [24] . All of these compounds have been reported to bind DNA, either through groove binding or intercalation. Several compounds showed good antimicrobial activity on both Gramnegative and Gram-positive bacteria, albeit that the latter are generally more sensitive to metal complexes [16, [21] [22] [23] [24] . These complexes have only been tested on planktonic cells, and we therefore sought to investigate the activity of a panel of copper(II) complexes against biofilms, and focussed this specifically on a clinical isolate of meticillin-resistant Staphylococcus aureus (MRSA) that is capable of forming stable 5 biofilms. The copper(II) complexes (compounds 1-9) are listed in Table 1, and their general structure is shown in Fig. 1 . We also assessed the influence of the central metal on biofilms by comparing the copper(II) containing compound 3 with analogous complexes containing either platinum(II) (compound 10) or palladium(II) (compound 11).
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MATERIALS AND METHODS
Strains and growth conditions
The bacterial strains used in this study were S. aureus MRSA252 and MSSA209 [25] , Enterococcus faecalis NCTC775, Escherichia coli NCTC86, and Pseudomonas aeruginosa ATCC27853. Strains were maintained on Tryptone Soy Agar (Oxoid).
Antimicrobial compounds
All metal complexes used (listed in Table 1 ) were synthesised as described [16, 24] .
Complexes were either dissolved in water (chloride salts) or DMSO (perchlorate salts) to 10 mg/mL. Vancomycin and chloramphenicol (Sigma-Aldrich) were dissolved in water and 96% ethanol, respectively.
Minimum inhibitory concentrations
The minimum inhibitory concentration (MIC) values for the complexes were determined with a microdilution broth method using Mueller Hinton Broth (Oxoid) as described [26] .
Biofilm assays in microtitre plates
An overnight culture of S. aureus MRSA252 grown in Brain Heart Infusion (BHI; Oxoid) broth supplemented with 0.5% glucose (BHI-G) was diluted 25- 
Visualisation of biofilms using confocal scanning laser microscopy
An overnight culture of S. aureus MRSA252 grown as above (Section 2.4) was diluted 25-fold in fresh BHI-G. This inoculum was dispensed (4 mL) into wells of a 
RESULTS
Antimicrobial activity
The antibacterial activity of the Cu(II) complexes chosen for this study has been reported before [16, 24] , but because the activity was not determined on the same panel of bacterial isolates, we re-evaluated their activity (Table 1) . This was compared with the activity of two antibiotics, vancomycin (compound 12) and chloramphenicol (compound 13). The copper compounds demonstrate similar activity on two S. aureus strains, irrespective of whether they are meticillin-sensitive (MSSA209) or resistant (MRSA252). The copper compounds are also similarly active against another Gram-positive bacterium, E. faecalis. Activity against Gram-negative bacteria is lower, with the compounds still showing some activity against E. coli but no significant activity against P. aeruginosa. Note that neither the ligands [16] , nor CuCl2 (compound 14; Table 1 ) have a high antimicrobial activity on their own; these have sublethal activity at the concentrations tested, and significant antimicrobial activity is only observed for the complexes of Cu(II) with the ligands.
Antibiofilm activity against S. aureus MRSA252
A number of copper complexes were chosen for further analysis on biofilms formed by S. aureus MRSA252. These included compounds 1-3, for which the cytotoxic activity is also known [24] , and the more hydrophobic and active compounds 7 and 8.
In addition, compound 9 ( Fig. 1 ) was used to analyse the effect of the absence of the diaminocyclohexane. It was observed that all of the copper compounds were capable of removing a significant amount of the biofilm at concentrations of 25 µg/mL or higher (Fig. 2) . Compared to the antibiotics vancomycin (12) and chloramphenicol (13) , all of the copper compounds were more effective in removing biofilms. At 25 µg/mL, chloramphenicol only removed 26% of the biofilm, compared to 60-68% for the compounds 1, 2 and 3, and 35-42% for compounds 7, 8 and 9. Particularly striking was the difference with vancomycin, since the MIC of this antibiotic on MRSA252
(0.25 µg/mL) is considerably better than that of the copper compounds (2-32 µg/mL).
Incubation for 24 h in the presence of 25 µg/mL vancomycin (which is 100-fold the MIC value) had even increased the biomass in the biofilm. Only in the presence of 100 µg/mL vancomycin was a reduction (by 44%) of the biofilm observed. Note that CuCl2 has no significant antibiofilm activity at the concentrations tested (compound 14, Fig. 2 ).
Analysis of antibiofilm activity by confocal microscopy
To visualise the effects on MRSA252 biofilms, cells were grown for 24 h on polyvinyl coverslips followed by a 2-h treatment with compound. Next, cells were stained with the BacLight Live/Dead stain in which living cells stain green and dead cells red. As shown in Fig. 3 , 2 h after addition of 100 µg/mL of compound 3 the majority of cells stained red, whereas in the presence of the same concentration of vancomycin most cells stained yellow-green. Thus, significantly more bacteria were killed in the presence of compound 3 as compared to vancomycin. In addition, biofilms incubated in the presence of vancomycin had not reduced in thickness (7 µm for non-treated biofilms, 10 µm for vancomycin-treated biofilms), but those incubated with compound 3 were reduced significantly to about 2 µm.
The copper compounds have no aspecific membrane activity
It is conceivable that the antibiofilm activity of compound 3 is not achieved through DNA binding, but that the compound has non-specific membrane activity instead. To verify this we analysed the effect of each of the copper compounds on cell membranes by testing for their ability to lyse red blood cells [27] . However, as shown in Table 1 the copper compounds have only a very low haemolytic activity, a level comparable to that of vancomycin and chloramphenicol.
Effects of the central metal
The antibiofilm activity demonstrated by complex 3 in Fig. 3 is also evident for the other Cu(II) compounds. An important question is whether the central metal influences their activity. To that purpose we tested the activity of three analogous
where M is copper (compound 3), platinum (compound 10) or palladium (compound 11) [16] . Both compound 10 and 11 were less active than complex 3 in standard MIC tests on planktonic cells, albeit that the Pt(II) compound has a similar activity to complex 3 on E. faecalis or E. coli (Table 1) . Surprisingly, compound 10 was significantly less active on S. aureus MRSA252 (MIC>128 µg/mL) than on MSSA, whereas such differences were not observed with other compounds.
Strikingly, neither complex 10 nor 11 were very active against biofilms formed by S. aureus MRSA252. A 24-h incubation of pre-formed biofilms with complex 10 resulted in only a 17% biomass reduction, while in the presence of complex 11 the biofilms increased in biomass (Fig. 2) .
DISCUSSION
We have previously shown that certain metal complexes have antibacterial activity.
Here we demonstrated that in particular Cu ( The activity of the different Cu(II) complexes on biofilms was fairly similar, albeit that at 25µg/mL complexes 1-3 were somewhat more active than 7 and 8.
Interestingly, the latter two were the most active on planktonic cells, possibly through enhance uptake or increased affinity with their target due to the increased hydrophobicity, but that did not translate into increased antibiofilm activity. The octahedral compound 9 (which does not contain 1,2-diaminocyclohexane) was similarly active to 7 and 8, indicating that the diaminocyclohexane is not essential for activity.
One of our initial hypotheses was that the Cu(II) compounds might bind extracellular DNA. This has been found to be an important component of the extracellular matrix of biofilms, and for instance DNAse treatment significantly reduces the biomass of biofilms of S. aureus and other bacteria [28] . However, a number of other DNAbinding metallo-complexes that we tested have no or barely any activity on biofilms, including the aforementioned compounds 10 and 11, as well as other compounds such as major groove-binding complexes of iron [22] or ruthenium [23] (data not shown). It is well known that many coordination complexes with copper, but not those with platinum or palladium, are redox active and can mediate DNA cleavage [17] . For instance, a 1,10-phenanthroline-copper complex was the first synthetic chemical nuclease reported [29] . This nuclease activity depends on the presence of exogenous reagents such as ascorbate, thiols or peroxide to produce active species that leads to DNA strand scission [30, 31] . We have previously shown that the Cu(II) complexes used here have indeed such nuclease activity [24] . This, together with the observation that replacing Cu(II) in compound 3 with Pt(II) (compound 10) or Pd(II) (compounds 11) significantly reduces antibacterial and antibiofilm activity, strongly suggests that this nuclease activity is an important mechanism by which the Cu(II) compounds are active. As mentioned above, this activity is dependent on the presence of reducing agents, which in bacteria could be supplied by low molecular mass thiols that maintain their cytoplasm in a strongly reducing state. In most Gram-negative bacteria the thiol used is glutathione, whereas in several Gram-positive bacteria including S.
aureus this is bacillithiol [32] . It is interesting to note that the previously published value of the half maximal inhibitory concentration (IC50) against a mouse cell line (L1210) is much lower for compound 10 (0.0092 µM) than for compound 3 (0.62 µM) or compound 11 (11.5 µM) [24] . Thus, on mammalian cells the Pt(II) compound is far more active than the Cu(II) or Pd(II) compounds, indicating that the mode of action of the complexes in mammalian cells is different from that in bacterial cells.
A question that remains is why the Cu(II) compounds are less active than vancomycin on planktonic cells, yet are significantly more active on biofilms. Important in this is that most antibiotics are particularly effective on rapidly dividing cells, as they inhibit processes that are more active in those cells, such as cell wall synthesis or protein translation. However, cells in biofilms often grow more slowly or are even in a dormant state, explaining the poor activity of antibiotics on biofilms [3] . Indeed, the cell-wall active vancomycin has been shown not to be very effective against S. aureus biofilms [33] . However, copper-induced DNA damage may lead to death irrespective of the physiological state or growth rate of the bacterial cells. This could thus explain that, in contrast to antibiotics such as vancomycin, the Cu(II) compounds effectively kill and remove biofilms at concentrations that are relatively close to the MIC values obtained for planktonic cells. It should be noted that, as mentioned before, other factors such as limited penetration into biofilms may also play a role in the antimicrobial resistance of biofilms [6, 7] , and it is conceivable that these further exacerbate the differences in antibiofilm activity observed for the Cu(II) compounds and vancomycin.
This initial work has demonstrated the effectiveness of copper compounds on biofilms of S. aureus MRSA252, and effects on biofilms of additional S. aureus isolates and other bacteria will be investigated in the near future. Whether the copper compounds can be used for systemic treatment of biofilm-related infections depends on further improvement of activity and specificity. The copper compounds do have some cytotoxicity as previously shown by us using a simple animal (nematode) model and the aforementioned L1210 cell line [24] , but it was encouraging to note the lack of non-specific membrane activity on mammalian red blood cells. Even if toxicity is too high, topical treatment of chronic wound infections, which are known to involve biofilms, may still be an option. For instance, the compounds could be used in wound dressings, and we plan to test the copper compounds in combination with novel slowrelease matrices [34] that could be used to this purpose. Another application of interest could be the incorporation of the copper complexes in materials of medical devices such as catheters, which are prone to biofilm-related infections [35] , in order to prevent biofilm formation. 
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